Epoprostenol is a potent vasodilator and antiplatelet substance with a very short physiologic half-life. It is used for the treatment of pulmonary hypertension. Epoprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF is on file with the US FDA, Canada, Japan, Australia, and many EU member states.